Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 10-Q, Date: 2011-05-23
Original SEC Filing: Click here

---

Webplus: SKBI/20110523/10-Q/1/000.htm SEC Original: v223770_10q.htm
SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART I.FINANCIAL INFORMATION 4 Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of March 31, 2011 (unaudited) and December 31, 2010 4ndensednsolidated Statements of Operations and Othermprehensiveome (Loss) for the Three Months Ended March 31, 2011 and 2010 (unaudited)

---

---

Webplus: SKBI/20110523/10-Q/3_EX-31.1/000.htm SEC Original: v223770_ex31-1.htm
SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light

---

---

Webplus: SKBI/20110523/10-Q/4_EX-31.2/000.htm SEC Original: v223770_ex31-2.htm
SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Michael H. Lan, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in

---

---

Webplus: SKBI/20110523/10-Q/5_EX-32.1/000.htm SEC Original: v223770_ex32-1.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Weibing Lu Chief Executive Officer May 23, 2011

---

---

Webplus: SKBI/20110523/10-Q/6_EX-32.2/000.htm SEC Original: v223770_ex32-2.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Michael H. Lan Chief Financial Officer May 23, 2011

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 10-Q, Date: 2011-05-23CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE